Africa BriefingAfrica Briefing

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    HIV vaccine trial in Africa halted over ineffectiveness concerns

    December 7, 2023

    Zimbabwe’s ZANU-PF angered by US visa restrictions

    December 7, 2023

    West African court dismisses Niger junta’s bid to lift ECOWAS sanctions

    December 7, 2023
    Facebook Twitter Instagram
    • Home
    • About Us
      • Profile
      • The Team
      • Advertise
      • Media Kit
    • Contact Us
    • Regions
      • Ghana
      • Nigeria
      • Kenya
      • South Africa
      • Europe
      • United Kingdom
      • USA (North America)
    Trending
    • HIV vaccine trial in Africa halted over ineffectiveness concerns
    • Zimbabwe’s ZANU-PF angered by US visa restrictions
    • West African court dismisses Niger junta’s bid to lift ECOWAS sanctions
    • Sierra Leone ex-president Koroma summoned over failed coup probe
    • Op-Ed: Ghana’s media treats terrorism as a threat from outside – it overlooks violence at home
    • Vista Group expands in Africa with acquisition of Société Générale subsidiaries
    • Mastercard Foundation’s Africa Growth Fund injects $200m to drive women and youth economic opportunities
    • US state sues Meta, Kenyan judge finds no contempt in moderator payment case
    0 Shopping Cart
    Facebook Twitter YouTube LinkedIn
    Africa BriefingAfrica Briefing
    Resources
    Support Us
    • News
    • Politics
    • Business
    • Energy
    • Technology
    • CryptoTech
      • Crypto News
      • Startups & Companies
      • Crypto Currencies
      • DeFi
      • Metaverse
      • NFTs
    • More
      • Videos
      • Opinion
    • Magazine
    Africa BriefingAfrica Briefing
    Home»Covd-19»South Africa’s Biovac to start making Pfizer Covid-19 vaccine in early 2022
    Covd-19

    South Africa’s Biovac to start making Pfizer Covid-19 vaccine in early 2022

    Editorial StaffBy Editorial StaffDecember 7, 2021No Comments2 Views
    Facebook Twitter WhatsApp Telegram
    The logo of South African vaccine manufacturing and storage company Biovac is seen outside the company's offices in Cape Town, South Africa, March 18, 2021. REUTERS/Mike Hutchings
    Share
    Facebook Twitter Telegram WhatsApp

    SOUTH Africa’s Biovac Institute will start making Pfizer-BioNTech’s  COVID-19 vaccine early next year after receiving the drug substance from Europe, a Pfizer executive said on Monday.

    Biovac’s ‘fill and finish’ deal with Pfizer, announced in July, will make it one of the few companies processing Covid-19 shots in Africa, where many countries have struggled to access sufficient doses during the pandemic.

    ‘We expect that the Cape Town facility will be incorporated into our supply chain by the end of this year,’ Patrick van der Loo, Pfizer regional president for Africa and the Middle East, told a conference in Kigali on vaccine manufacturing in Africa.

    ‘Biovac will obtain the drug substance from facilities in Europe and manufacturing of finished doses will commence early in 2022,’ he said, appearing by video link.

    Large Western pharmaceutical companies including Pfizer have been widely criticised for not doing enough to facilitate vaccine production in developing countries.

    In July Pfizer’s CEO urged World Trade Organisation members not to support a waiver on some intellectual property rights for Covid-19 vaccines – a proposal by South Africa and India.

    Biovac’s deal with Pfizer covers the final stages of manufacturing, where the vaccine is processed and put into vials, but does not represent a transfer of the intellectual property underpinning the vaccine.

    Van der Loo listed what he described as historical challenges faced by pharmaceutical companies on the continent, saying these explained the difficulties in kickstarting local vaccine manufacturing.

    Among them were irregular power and water supplies, which have been an issue in South Africa over the years.

    ‘Last year … water was rationed, which made it very difficult both practically but also ethically to obtain and use large quantities of water for trial runs through the equipment as part of our start-up tech transfer phase,’ he said, referring to operations at the Biovac facility.

     

    Share. Facebook Twitter Telegram WhatsApp

    Related Posts

    Op-Ed: Examining Africa’s preparedness in the wake of a new wave of Covid-19 infections

    October 9, 2023

    Remaining Covid-19 vaccine funds could shift to pandemic preparedness and African vaccine manufacturing

    June 26, 2023

    African Development Bank commits to supporting East Africa’s structural transformation and regional integration

    June 7, 2023
    Add A Comment

    Comments are closed.

    Top Posts

    Sex tourism: The Gambia is fed up with UK grandmothers hunting for toy boys

    September 19, 20225,693

    Op-Ed: Qatar World Cup 2022 – prejudice, coordinated attacks and Western grandstanding

    November 4, 20222,534

    Ghanaian architect of UK’s Black History Month honoured by prestigious British university

    December 12, 20222,187

    Turkey seizes $1 billion of counterfeit money bound for Africa

    June 10, 20231,960
    Don't Miss
    Development

    HIV vaccine trial in Africa halted over ineffectiveness concerns

    By Editorial StaffDecember 7, 2023130

    A TRIAL of an experimental HIV vaccine in Uganda, Tanzania and South Africa has been…

    Zimbabwe’s ZANU-PF angered by US visa restrictions

    December 7, 2023

    West African court dismisses Niger junta’s bid to lift ECOWAS sanctions

    December 7, 2023

    Sierra Leone ex-president Koroma summoned over failed coup probe

    December 7, 2023
    Stay In Touch
    • Facebook
    • Twitter
    • YouTube
    • LinkedIn
    About Us
    About Us

    AfricaBriefing is a monthly magazine designed to provide news and information on Africa to Africans at home and abroad, and the wider global audience that has a committed interest in the continent’s political, economic and social developments.

    Facebook Twitter YouTube LinkedIn
    Our Picks

    HIV vaccine trial in Africa halted over ineffectiveness concerns

    December 7, 2023

    Zimbabwe’s ZANU-PF angered by US visa restrictions

    December 7, 2023

    West African court dismisses Niger junta’s bid to lift ECOWAS sanctions

    December 7, 2023
    Most Popular

    Sex tourism: The Gambia is fed up with UK grandmothers hunting for toy boys

    September 19, 20225,693

    Op-Ed: Qatar World Cup 2022 – prejudice, coordinated attacks and Western grandstanding

    November 4, 20222,534

    Ghanaian architect of UK’s Black History Month honoured by prestigious British university

    December 12, 20222,187
    © 2023 AfricaBriefing.

    Type above and press Enter to search. Press Esc to cancel.

    Privacy Policy & Cookie Management
    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. Read more: Read More
    Do not sell my personal information.
    Cookie SettingsAccept
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT